Published in AIDS Weekly, July 5th, 2004
In a letter sent to Abbott, the FDA said a comparative-cost chart for the Norvir soft gelatin capsules was "false and misleading" because it claims the drug has the lowest daily cost of all antiretrovirals.
The FDA said the chart also improperly implied Norvir might be used alone in some cases - when its instructions say it is for use in small doses to boost the potency of AIDS combination-drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.